Aimed Alliance Provides Testimony of UPLs Before New Jersey’s PDAC
On March 19, 2026, Aimed Alliance provided testimony to the New Jersey Prescription Drug Affordability…
Browsing: Federal
Aimed Alliance Submits Comment on FTC’s Proposed Settlement with Express Scripts
On March 16, Aimed Alliance submitted a comment on the proposed settlement between the Federal…
Aimed Alliance Pushes Back on PDAB Legislation in Illinois
On March 18, 2026, Aimed Alliance submitted comments to the Health Care Availability & Accessibility…
Aimed Alliance Urges Amendments to Virginia’s PDAB Bill to Protect Patient Access
On March 13, 2026, Aimed Alliance sent a letter to Governor Abigail Spanberger urging amendments…
Administration Targets Foreign Drug Pricing in Upcoming Section 301 Investigation
Recently, the Trump Administration announced plans to initiate a new Section 301 investigation into foreign…
Aimed Alliance Supports CA Copay Accumulator Ban
Aimed Alliance recently sent a letter to the California legislature urging for the ban of…
FDA Confirms AFPs Not Permissible Under Section 804
On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration…
Minnesota Reports $1.34 Billion in 340B Revenue
Minnesota’s second year of 340B reporting shows that Covered Entities generated at least $1.34 billion…
Aimed Alliance Urges Maryland PDAB to Protect Patient Access in UPL Deliberations
Aimed Alliance sent letters to the Maryland PDAB urging it to proceed cautiously with setting…
GLOBE Model Expected to Have Minimal Impact on Part B OOP Costs
A new analysis published by Avalere Health found that the proposed GLOBE (Global Benchmark for Efficient…